Treatment of these hepatocytes with CF led to a reduction in PCSK9 expression and secretion (Fig. S3B, C), suggesting that AMPK is not directly involved in CF-mediated PCSK9 inhibition. Here, PCSK9 is linked to cystic fibrosis.